Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1978-12-01
1981-09-29
Schenkman, Leonard
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
562594, A61K 3119
Patent
active
042923263
ABSTRACT:
There is disclosed a composition for the treatment of acne, hyperpigmentary dermatoses or skin hyperpigmentation which contains dicarboxylic acids containing 7 to 13 carbon atoms or certain derivatives thereof that contain reducing functional group or a salt thereof. There are also disclosed methods for preparing mercapto derivatives of these dicarboxylic acids.
REFERENCES:
patent: 2402639 (1946-06-01), Lazier et al.
patent: 2581514 (1952-01-01), Chilcotte
patent: 2602815 (1952-07-01), Gregory et al.
patent: 2657231 (1953-10-01), Klarer et al.
patent: 2729675 (1956-01-01), Cowen
patent: 3066077 (1962-11-01), De Mytt
Porro et al., Gior. e Min. Derm., pp. 207-209 (B-1977).
Chemical Abstracts 66:1860e (1967).
Chemical Abstracts T4:16659(c) (1960).
"Malignant Melanoma", Kopf et al., Mason Pub., 1979, p. 7.
LandOfFree
Process for treatment of hyperpigmentary dermatoses does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for treatment of hyperpigmentary dermatoses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for treatment of hyperpigmentary dermatoses will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1233986